Last $6.50 USD
Change Today +0.39 / 6.38%
Volume 20.6K
CDNA On Other Exchanges
As of 5:20 PM 03/2/15 All times are local (Market data is delayed by at least 15 minutes).

caredx inc (CDNA) Snapshot

Previous Close
Day High
Day Low
52 Week High
09/8/14 - $10.89
52 Week Low
10/20/14 - $5.40
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for CAREDX INC (CDNA)

Related News

No related news articles were found.

caredx inc (CDNA) Related Businessweek News

No Related Businessweek News Found

caredx inc (CDNA) Details

CareDx, Inc, a commercial stage company, develops, markets, and delivers a diagnostic surveillance solution for heart transplant recipients to help clinicians make personalized treatment decisions throughout a patient’s lifetime. Its commercialized testing solution includes the AlloMap heart transplant molecular test (AlloMap), a blood-based test used to aid in the identification of heart transplant recipients with stable organ function and a low probability of moderate or severe rejection. The company markets AlloMap to healthcare providers through its direct sales force that targets transplant centers and their physicians, coordinators, and nurse practitioners in the United States, Canada, and Europe. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. CareDx, Inc. was incorporated in 1998 and is based in Brisbane, California.

55 Employees
Last Reported Date: 07/18/14
Founded in 1998

caredx inc (CDNA) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $350.0K
Chief Medical Officer and Executive Vice Pres...
Total Annual Compensation: $365.7K
Chief Compliance Officer and Chief Business O...
Total Annual Compensation: $308.3K
Compensation as of Fiscal Year 2013.

caredx inc (CDNA) Key Developments

CareDx, Inc Enters into a Loan and Security Agreement with East West Bank

On January 30, 2015, CareDx Inc. entered into a Loan and Security Agreement with East West Bank. The Loan Agreement provides a secured term loan facility in an aggregate principal amount of up to $20.0 million. The Company borrowed the first advance of $16.0 million (Draw A) on January 30, 2015. Under the terms of the Loan Agreement, following a six month period from the closing date and until any time before December 31, 2015, the Company may, at its option, borrow from Lender a second advance of $4.0 million (Draw B), subject to the Company's satisfaction of certain conditions described in the Loan Agreement, including the Company achieving at least, measured on a trailing six month basis, 80% of its board approved net product revenue plan.

CareDx, Inc Presents at Leerink's Global Healthcare Conference, Feb-11-2015 10:40 AM

CareDx, Inc Presents at Leerink's Global Healthcare Conference, Feb-11-2015 10:40 AM. Venue: Waldorf Astoria New York, New York, New York, United States. Speakers: Kenneth E. Ludlum, Chief Financial Officer, Peter Maag, Chief Executive Officer, President and Director.

CareDx, Inc. Appoints John J. Sninsky as Chief Scientific Officer

CareDx Inc. announced the appointment of Dr. John J. Sninsky as Chief Scientific Officer. Dr. Sninsky brings a wealth of experience in the discovery, development and application of diagnostic technologies, content and interpretive test solutions, having most recently served as the Vice President of Discovery Research at Celera Corporation. Following Celera's acquisition by Quest Diagnostics, he served as the Alameda site head for Quest's Science & Innovation and oversaw organization-wide Bioinformatics. Dr. Sninsky brings significant experience ranging from early stage biotechnology to international pharmaceutical organizations as well as a range of CLIA and IVD product settings.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CDNA:US $6.50 USD +0.39

CDNA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for CDNA.
View Industry Companies

Industry Analysis


Industry Average

Valuation CDNA Industry Range
Price/Earnings 100.0x
Price/Sales 2.2x
Price/Book 1.8x
Price/Cash Flow 321.9x
TEV/Sales 0.8x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CAREDX INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at